InsidersTradesSigma
Explore the detailed record of transactions filed by Clausen Peter, 首席运营官. Insider active across 1 company, notably Nuo Therapeutics, Inc.. Cumulatively, 1 disclosures have been recorded. Activity tracked since 29 April 2022. The latest transaction was filed on 29 April 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Peter Clausen is the Chief Scientific Officer and Chief Operating Officer at Nuo Therapeutics, Inc. He is responsible for the strategic direction of operations and research and development. His expertise is essential for ensuring innovation and efficiency within the company.